Healthtech: the one category quick commerce got right
Telemedicine's one-off consult model proved thin on trust. The real healthtech wedge is narrow, high-frequency chronic care, or B2B infrastructure for hospitals and pharmacies.
Aug 12, 2026
Medicine came up before as the one quick-commerce category with real, not manufactured, urgency. Healthtech deserves its own space because that logic runs past delivery speed into diagnosis, ongoing care, and access, and most of the category hasn't actually earned the urgency it claims.
Generic telemedicine had its moment and mostly proved the trust deficit, not the tech gap. A video call with a stranger for a real health decision isn't the same ask as a video call for a customer support issue. Usage spiked during a period people had no other option and fell back hard the moment they did, because one-off consult apps never got the chance to build the repeat relationship trust that health decisions actually require.
The wedge that works is narrow and high-frequency: chronic condition management, diabetes, hypertension, ongoing care that needs to happen weekly or monthly, not once. Repeat usage is what builds real trust and a real data asset over time, the same difference between a habit and a transaction that shows up everywhere else on this list. One good consult doesn't build a company. A hundred small, trusted touchpoints does.
The B2B side mirrors quick commerce again. A hospital or pharmacy's supply chain and operations software is bought out of operational necessity, not convinced into with a marketing budget, and that buyer doesn't churn the way a consumer app does the moment a habit loop gets boring.
I'm looking for founders who picked either a genuinely narrow, repeat-usage chronic-care wedge, or B2B healthcare infrastructure, not founders chasing the same overhyped one-off telemedicine wave that already proved thin once.
Get new essays and theses by email
More theses